ADXN Award Disclosure
Teyssedou Lenaic Nathanael · SEC Form 4 · Filed Sep 4, 2026
Award
Calculated transaction value
$0
Teyssedou Lenaic Nathanael Principal Accounting Officer
ADXN
Transaction date
Sep 2, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 2 days later
ADXN daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock-option (Right to Buy) on Common Stock
- Quantity / price
- 100,485 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001104659-26-105509
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Award | Sep 2, 2026 | $0 |
| Addex Therapeutics Ltd. ADXN | Disposition | Sep 2, 2026 | $0 |